One-year follow-up of a multifocal intraocular lens with optimized elevated phase shift.

EPS 2.0 restored patient's vision in the full range of field with a nearly monotone decrease of visual performance from far to near, achieving high rates of spectacle independence at all distances and with low positive dysphotopsia rates (ClinicalTrials.gov Identifier: NCT05735990).